1
Mufson Daniel, Hanson Musetta A: Enhancement of intranasal absorption of calcitonin by formulation with surfactants.. Armour Pharma, August 15, 1984: EP0115627-A1 (31 worldwide citation)

A pharmaceutical composition for the treatment of disorders of bone metabolism which comprises an aqueous or non-aqueous medium suitable for intranasal administration and containing a therapeutically effective amount of colcitonin and a surface active agent.


2
Improvements in or relating to pastille formulations. Armour Pharma, Robert Barrie Christie, March 12, 1969: GB1144915-A (28 worldwide citation)

1,144,915. Pastilles. ARMOUR PHARMACEUTICAL CO. Ltd. and R. B. CHRISTIE. 23 Nov., 1967 [24 Nov., 1966], No. 52599/66. Heading A5B. A pharmaceutical pastille is composed of two parts which dissolve in the mouth at dissimilar rates. The two parts may be present as layers "side by side" or one may be p ...


3

4
Murray Robert W, Nelson Roger E, Rubino Andrew M: Method of preparing enhanced efficacy aluminum chlorhydrate antiperspirant and antiperspirant composition.. Armour Pharma, June 4, 1986: EP0183171-A2 (17 worldwide citation)

Two-thirds to five-sixths basic aluminum chlorides having enhanced antiperspirant efficacy are produced by heating an aqueous solution containing about 40 to about 50 weight percent of the basic aluminum chloride to a temperature of at least about 130 degrees C for about one to twelve hours in a clo ...


5
Amphlett Godfrey A, Hrinda Michael E: Process for purifying factor viii:c.. Armour Pharma, June 19, 1985: EP0144957-A2 (15 worldwide citation)

Factor VIII:C is purified by chromatographic absorption on aminohexyl agarose at a pH above 5.5 up to about 8, and preferably 6.5 to 7.2, and a conductivity of about 25 to about 35 mS/cm.


6

7
Injection devices. Armour Pharma, March 31, 1976: GB1430092-A (13 worldwide citation)

1430092 Injection devices ARMOUR PHARMACEUTICAL CO LTD 26 July 1973 [17 Aug 1972] 38495/72 Heading A5R An injection device comprises a hollow needle 10 which may be used as a catheter guide and which is secured at its proximal end to a handle 14 by a cylindrical collar 13 fitting tightly about the n ...


8
Landaburu Ricardo H, Amphlett Godfrey, Branson Roy E, Shaw Arthur B: Process for pasteurizing fibronectin.. Armour Pharma, November 7, 1984: EP0124044-A2 (12 worldwide citation)

A process for heat treatment of a fibronectin solution sufficient to inactivate viruses therein while preserving its physical and biological properties in the presence of a polyol, a surface active agent and a chelating agent.


9
Jurgen Dietrich Friedrich Fiechtl, Bernhard Kerner, Jurgen Holzapfel, Martin Puschmann, Tokusuke Kimura, Fumio Kurosu: Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer. Armour Pharma, Wegner & Bretschneider, May 30, 1989: US04835257 (10 worldwide citation)

An improved process for the preparation of gamma globulin suitable for intravenous administration comprises dissolving gamma globulin precipitated from blood or blood products in a solution, separating non-dissolved precipitate from the solution, adding polyethylene glycol to the separated solution, ...


10
Anti-inflammatory preparations. Armour Pharma, September 29, 1965: GB1005985-A (10 worldwide citation)

An anti-inflammatory preparation for oral, parenteral, topical, rectal, and vaginal administration, consists of an anti-inflammatory enzyme and an anti-inflammatory steroid. Specified enzymes are trypsin, chymotrypsin, bromelin, ficin, streptokinase, streptodornase, collagenase, papain, pancreatic e ...